TIAA CREF Investment Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-88,464
| Closed | -$1.59M | – | 3109 |
|
|
2017
Q4 | $1.59M | Sell |
88,464
-8,212
| -8% | -$101K | ﹤0.01% | 2255 |
|
|
2017
Q3 | $1.14M | Hold |
96,676
| – | – | ﹤0.01% | 2458 |
|
|
2017
Q2 | $1.01M | Sell |
96,676
-16,380
| -14% | -$167K | ﹤0.01% | 2544 |
|
|
2017
Q1 | $1.24M | Sell |
113,056
-85,924
| -43% | -$997K | ﹤0.01% | 2406 |
|
|
2016
Q4 | $2.7M | Sell |
198,980
-14,690
| -7% | -$205K | ﹤0.01% | 2018 |
|
|
2016
Q3 | $2.63K | Sell |
213,670
-3,493
| -2% | -$41.2K | ﹤0.01% | 2026 |
|
|
2016
Q2 | $2.38M | Sell |
217,163
-2,288
| -1% | -$25.6K | ﹤0.01% | 2008 |
|
|
2016
Q1 | $2.4M | Buy |
219,451
+11,241
| +5% | +$142K | ﹤0.01% | 1967 |
|
|
2015
Q4 | $3.6M | Buy |
208,210
+16,785
| +9% | +$301K | ﹤0.01% | 1785 |
|
|
2015
Q3 | $3.8M | Sell |
191,425
-21,111
| -10% | -$484K | ﹤0.01% | 1727 |
|
|
2015
Q2 | $3.49M | Buy |
212,536
+153,684
| +261% | +$2.66M | ﹤0.01% | 1936 |
|
|
2015
Q1 | $916K | Sell |
58,852
-2,852
| -5% | -$44.2K | ﹤0.01% | 2664 |
|
|
2014
Q4 | $881K | Buy |
61,704
+1,092
| +2% | +$11.5K | ﹤0.01% | 2725 |
|
|
2014
Q3 | $394K | Sell |
60,612
-3,247
| -5% | -$21.6K | ﹤0.01% | 3021 |
|
|
2014
Q2 | $441K | Buy |
63,859
+10,827
| +20% | +$76.6K | ﹤0.01% | 3033 |
|
|
2014
Q1 | $379K | Hold |
53,032
| – | – | ﹤0.01% | 3012 |
|
|
2013
Q4 | $499K | Hold |
53,032
| – | – | ﹤0.01% | 2960 |
|
|
2013
Q3 | $331K | Sell |
53,032
-5,290
| -9% | -$33K | ﹤0.01% | 3017 |
|
|
2013
Q2 | $384K | Buy |
+58,322
| New | +$463K | ﹤0.01% | 2991 |
|
Other funds holding SCMP
TIAA CREF Investment Management's SCMP Position: Q1 2018 in Review
TIAA CREF Investment Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 88,464 shares — an estimated $1.59M sold.
TIAA CREF Investment Management first reported a position in SCMP in Q2 2013 and held it in 19 quarters. The position peaked at $3.8M in Q3 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.
- TIAA CREF Investment Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- TIAA CREF Investment Management sold 88,464 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.59M.
- TIAA CREF Investment Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
- TIAA CREF Investment Management's Sucampo Pharmaceuticals, Inc. position peaked at $3.8M in Q3 2015.
- 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.
Based on TIAA CREF Investment Management's 13F filing for Q1 2018, filed 14 May 2018.